Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Interventional × Arthritis, Psoriatic × guselkumab × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Arthritis, Psoriatic 2 Adenomatous Polyposis Coli 1

Interventions

guselkumab 2 tofacitinib 1 sonelokimab 1 risankizumab 1 Vaccines 1 Specimen Handling 1 Saline Solution 1 Nivolumab 1 Infliximab 1 Herpes Zoster Vaccine 1 Etanercept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04936308 2026-03-12

SOLSTICE

Janssen Research & Development, LLC

Phase 3 Active not recruiting

453 enrolled 25 charts

Arthritis, Psoriatic

NCT03162796 2021-02-03

Discover-1

Janssen Research & Development, LLC

Phase 3 Completed

383 enrolled 106 charts

Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡